LWM
GILD icon

LeConte Wealth Management’s Gilead Sciences GILD Stock Holding History

LeConte Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Buy
2,468
+121
+5% +$15.9K 0.17% 100
2026
Q1 		$327K Buy
2,347
+107
+5% +$15K 0.21% 84
2025
Q4 		$275K Sell
2,240
-35
-2% -$4.25K 0.18% 90
2025
Q3 		$253K Buy
+2,275
New +$259K 0.17% 94

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LeConte Wealth Management's GILD Position: Q2 2026 in Review

LeConte Wealth Management increased its Gilead Sciences (GILD) stake by 5.2% in Q2 2026, buying an estimated $15.9K and bringing the position to 2,468 shares worth $312K. The position accounts for 0.17% of the portfolio, ranked #100.

LeConte Wealth Management first reported a position in GILD in Q3 2025 and has held it in 4 quarters since. The position peaked at $327K in Q1 2026. 2,282 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • LeConte Wealth Management held 2,468 shares of Gilead Sciences worth $312K as of Q2 2026.
  • LeConte Wealth Management bought 121 Gilead Sciences shares in Q2 2026, an estimated $15.9K.
  • Gilead Sciences made up 0.17% of LeConte Wealth Management's portfolio in Q2 2026, its #100 holding.
  • LeConte Wealth Management first reported a position in Gilead Sciences in Q3 2025 and has held it in 4 quarters since.
  • LeConte Wealth Management's Gilead Sciences position peaked at $327K in Q1 2026.
  • 2,282 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on LeConte Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.